Supportive Management of Patients with Advanced Pheochromocytomas and Paragangliomas Receiving PRRT

Peptide receptor radionuclide therapy (PRRT) is used to treat patients with advanced malignant pheochromocytomas (PCCs) and paragangliomas (PGLs). Patients are at risk of a PRRT-induced catecholamine crisis, and standard guidelines regarding the prevention and management of infusion reactions are la...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsang, Erica S., Funk, Gayle, Leung, Janet, Kalish, Grace, Kennecke, Hagen F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395467/
https://www.ncbi.nlm.nih.gov/pubmed/34436013
http://dx.doi.org/10.3390/curroncol28040247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395467/
https://www.ncbi.nlm.nih.gov/pubmed/34436013
http://dx.doi.org/10.3390/curroncol28040247

Ejemplares similares